DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,954,648 | -24.9% | 24,001 | -27.3% | 0.12% | -28.5% |
| Q2 2023 | $7,926,240 | +57.2% | 33,026 | +65.1% | 0.17% | +41.0% |
| Q1 2023 | $5,043,068 | +6.9% | 20,009 | +12.6% | 0.12% | -8.3% |
| Q4 2022 | $4,716,513 | -1.4% | 17,770 | -4.0% | 0.13% | -7.0% |
| Q3 2022 | $4,782,000 | -15.0% | 18,514 | -16.6% | 0.14% | -21.0% |
| Q2 2022 | $5,625,000 | -20.0% | 22,189 | -7.4% | 0.18% | -17.0% |
| Q1 2022 | $7,031,000 | +2.2% | 23,968 | +14.6% | 0.22% | -1.8% |
| Q4 2021 | $6,879,000 | +0.6% | 20,908 | -6.9% | 0.22% | -19.9% |
| Q3 2021 | $6,840,000 | -29.2% | 22,467 | -37.6% | 0.28% | -32.4% |
| Q2 2021 | $9,667,000 | +22.0% | 36,023 | +2.3% | 0.41% | +16.1% |
| Q1 2021 | $7,923,000 | -45.4% | 35,200 | -46.1% | 0.35% | -26.5% |
| Q4 2020 | $14,520,000 | +74.4% | 65,364 | +69.1% | 0.48% | +79.8% |
| Q3 2020 | $8,324,000 | +134.5% | 38,656 | +92.6% | 0.27% | +151.9% |
| Q2 2020 | $3,549,000 | -29.2% | 20,068 | -44.6% | 0.11% | -23.7% |
| Q1 2020 | $5,012,000 | -17.3% | 36,208 | -8.3% | 0.14% | +25.2% |
| Q4 2019 | $6,063,000 | -20.8% | 39,502 | -25.5% | 0.11% | -17.8% |
| Q3 2019 | $7,657,000 | -17.9% | 53,015 | -18.8% | 0.14% | -9.4% |
| Q2 2019 | $9,326,000 | -1.2% | 65,255 | -8.8% | 0.15% | +8.0% |
| Q1 2019 | $9,442,000 | +76.0% | 71,521 | +37.5% | 0.14% | +66.3% |
| Q4 2018 | $5,365,000 | -70.2% | 52,028 | -68.6% | 0.08% | -66.7% |
| Q3 2018 | $18,030,000 | -20.9% | 165,928 | -28.2% | 0.25% | -24.5% |
| Q2 2018 | $22,800,000 | +90.6% | 231,053 | +89.2% | 0.33% | +97.6% |
| Q1 2018 | $11,960,000 | +1.4% | 122,152 | -3.8% | 0.17% | -2.3% |
| Q4 2017 | $11,792,000 | +414.7% | 127,041 | +375.6% | 0.17% | +402.9% |
| Q3 2017 | $2,291,000 | -90.1% | 26,710 | -90.1% | 0.03% | -88.4% |
| Q1 2017 | $23,034,000 | -29.7% | 269,309 | -36.0% | 0.29% | -30.8% |
| Q4 2016 | $32,747,000 | -29.9% | 420,700 | -29.4% | 0.42% | -30.6% |
| Q3 2016 | $46,728,000 | +1714.0% | 596,095 | +1864.7% | 0.61% | +2940.0% |
| Q1 2015 | $2,576,000 | -69.4% | 30,340 | -69.1% | 0.02% | -70.6% |
| Q4 2014 | $8,425,000 | +40.3% | 98,293 | +24.4% | 0.07% | +13.3% |
| Q3 2014 | $6,003,000 | +25.9% | 79,007 | +30.5% | 0.06% | 0.0% |
| Q2 2014 | $4,768,000 | -79.2% | 60,559 | -80.2% | 0.06% | -82.6% |
| Q1 2014 | $22,940,000 | +1265.5% | 305,861 | +1305.5% | 0.34% | +762.5% |
| Q4 2013 | $1,680,000 | +18.2% | 21,761 | +6.1% | 0.04% | -13.0% |
| Q3 2013 | $1,421,000 | -14.1% | 20,506 | -21.6% | 0.05% | -35.2% |
| Q2 2013 | $1,655,000 | – | 26,143 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |